FDA
-
-
-
-
-
-
-
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
-
-
-
-
-
-
-
Beta Technologies completes first FAA eVTOL program flights carrying organs
-
-
-
-
-
-
-
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
-
-
-
-
-
-
-
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
-
-
-
-
-
-
-
United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
-
-
-
-
-
-
-
United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis
-
-
-
-
-
-
-
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
-
333,162 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


